Search by Drug Name or NDC
NDC 17856-0799-02 MYLICON 20 mg/.3mL Details
MYLICON 20 mg/.3mL
MYLICON is a ORAL SUSPENSION in the HUMAN OTC DRUG category. It is labeled and distributed by ATLANTIC BIOLOGICALS CORP.. The primary component is DIMETHICONE.
MedlinePlus Drug Summary
Simethicone is used to treat the symptoms of gas such as uncomfortable or painful pressure, fullness, and bloating. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 17856-0799-02Last Updated: 03/24/2024
MedLinePlus Full Drug Details: Simethicone
Product Information
| NDC | 17856-0799 |
|---|---|
| Product ID | 17856-0799_eb3941c1-96e7-4bf4-9baf-d18398829439 |
| Associated GPIs | |
| GCN Sequence Number | 082810 |
| GCN Sequence Number Description | simethicone SYRINGE 20MG/0.3ML ORAL |
| HIC3 | D4N |
| HIC3 Description | ANTIFLATULENTS |
| GCN | 51467 |
| HICL Sequence Number | 001224 |
| HICL Sequence Number Description | SIMETHICONE |
| Brand/Generic | Generic |
| Proprietary Name | MYLICON |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Simethicone |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 20 |
| Active Ingredient Units | mg/.3mL |
| Substance Name | DIMETHICONE |
| Labeler Name | ATLANTIC BIOLOGICALS CORP. |
| Pharmaceutical Class | Skin Barrier Activity [PE] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part332 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 17856-0799-02 (17856079902)
| NDC Package Code | 17856-0799-2 |
|---|---|
| Billing NDC | 17856079902 |
| Package | 120 SYRINGE in 1 BOX, UNIT-DOSE (17856-0799-2) / .3 mL in 1 SYRINGE |
| Marketing Start Date | 2023-04-06 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |